Life Sciences consulting
The healthcare landscape is shifting. Discover how we're helping companies deliver better patient outcomes.
Life sciences is evolving rapidly from selling products to delivering value through a better patient outcomes.
We work with our pharmaceutical, biotech, medical technology, distributor and consumer health clients globally to redefine the future of the life sciences industry: combining the latest technology with scientific breakthroughs to revolutionize how medical treatments are discovered, developed and delivered to patients around the world.
New science: Biopharma’s new growth engine
Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and deliver better patient outcomes.READ MORE
Accenture Life Sciences offers a full range of services and an integrated platform (INTIENT) that help deliver more personalized healthcare and better outcomes for patients.
Life Sciences 2019 Technology Vision reveals several trends that are collectively paving the way to the future of life sciences.
Our Life Sciences solutions are helping businesses deliver exceptional patient experiences. Discover how our awards distinguish us as an industry leader.
Recognized by Frost & Sullivan
Recognized by IDC MarketScape
Recogized by Everest Group
We are proud to collaborate with leading women in life sciences in their quest to advance science and patient care.
We were honored when Carol Rohl, the Executive Director of Global Research Information Technology (IT) at Merck Research Labs, agreed to sit down with us to talk about the exciting role that she currently holds. It quickly became apparent how Carol had achieved so much in her career so far, given her warm and open personality.
Life Sciences consultants weigh in on how pharma, biotech, medtech and consumer health companies can improve patient outcomes.
Accenture has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes.
Despite preferring services from patient organizations over those from pharmaceutical companies, patients want both to work together to provide a more seamless patient experience.